Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like Vivasure Medical Enrolls First Patient In Frontier IV Clinical Trial October 12, 2017 Massachusetts' Exosome Diagnostics Snags $30 Million July 24, 2017 Spark, Pfizer's Gene Therapy Hemophilia B Drug Stuns in Trial December 6, 2017
